Alembic Pharma Panelav facility successfully completes ANVISA GMP audit Ruchika Sharma11 Dec 2024 2:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has informed the exchange that the Company has successfully completed the Brazilian Health Regulatory...
6 step-down subsidiaries of Alembic Pharma dissolves Ruchika Sharma9 Dec 2024 3:02 PM ISTVadodara: Alembic Pharma has informed in a BSE filing that six step-down subsidiaries of the Company have been dissolved/ in the process of...
Alembic Pharma bags USFDA tentative approval for Olopatadine Hydrochloride Ophthalmic Solution to treat itchy eyes Ruchika Sharma4 Dec 2024 3:46 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Tentative Approval from the US Food & Drug Administration...
USFDA Inspection: Alembic Pharma gets form 483 with 5 procedural observations for Gujarat plant Farhat Nasim25 Nov 2024 3:47 PM ISTThe US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility.
Alembic Pharma bags USFDA nod for Ivabradine Tablets Ruchika Sharma12 Nov 2024 4:05 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for...
Alembic Pharma bags USFDA nod for hypertension drug Diltiazem Hydrochloride ER Ruchika Sharma11 Nov 2024 12:05 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
Alembic Pharma gets USFDA nod to Diltiazem Hydrochloride ER Capsules to treat hypertension MD Bureau22 Oct 2024 2:20 PM ISTMumbai: Drug maker Alembic Pharmaceuticals Ltd has recently announced that it has received final approval from the United States Food and Drug...
DCGI bans this popular anti-cold FDC for children under 4 Farhat Nasim14 Oct 2024 4:25 PM ISTNew Delhi: The Drug Controller General of India (DCGI) has banned use of popular anti-cold cocktail medicine combination for children under four years...
Alembic Pharma successfully completes USFDA inspection at Panelav Oncology formulation facility Ruchika Sharma9 Oct 2024 11:20 AM ISTVadodara: Alembic Pharma has announced that the Company has successfully completed the United States Food and Drug Administration (USFDA)...
Alembic Pharma gets USFDA nod for Alcaftadine Ophthalmic Solution Ruchika Sharma4 Oct 2024 11:30 AM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration...
Alembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER Ruchika Sharma3 Oct 2024 1:33 PM ISTVadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Alembic Pharma receives USFDA EIR for Oral solid formulation facility (F-1) at Panelav Ruchika Sharma28 Sept 2024 4:37 PM ISTVadodara: Alembic Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the...
